Establishment of a Prognostic Prediction and Drug Selection Model for Patients with Clear Cell Renal Cell Carcinoma by Multiomics Data Analysis

Figure 2

The risk landscape of ccRCC and the intracluster heterogeneity within subtypes. (a) The subtype of ccRCC clustered by state. (b) The risk-related mRNA landscape of ccRCC: each point represents a patient with colors corresponding to the subtype defined previously. (c) Patients of CS1 subtype could be further stratified into three subgroups based on their location in the risk-related mRNA landscape. (d) Patients of CS2 subtype could be further stratified into two subgroups based on their location in the risk related mRNA landscape. (e, f) The three subgroups of patients in CS1 as stratified by the risk-related mRNA landscape were associated with distinct prognoses of OS and PFI. Log-rank value was calculated among subgroup stratification. (g, h) The two subgroups of patients in CS2 as stratified by the risk-related mRNA landscape were associated with distinct prognoses of OS and PFI. Log-rank value was calculated among subgroup stratification.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)